A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...
Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...
Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...
Bezuclastinib plus sunitinib showed favorable safety and efficacy in GIST, outperforming sunitinib alone in phase 3 Peak ...
Taken together, the above findings suggest that tumor stroma is far from a passive bystander during tumor metastases. Tumor cells influence stromal changes including remodeling of the ECM ...
Management trends and outcomes of appendiceal cancers: A National Cancer Database study. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...
GSK has announced that it will be expanding its gastrointestinal (GI) cancer pipeline by acquiring IDRx in a deal ... being developed as a first- and second-line therapy for gastrointestinal stromal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results